J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chart, H.
Right arrow Articles by Cheasty, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chart, H.
Right arrow Articles by Cheasty, T.
Agricola
Right arrow Articles by Chart, H.
Right arrow Articles by Cheasty, T.
J Med Microbiol 52 (2003), 569-572; DOI: 10.1099/jmm.0.05126-0
© 2003 Society for General Microbiology
ISSN 0022-2615

Analysis of saliva for antibodies to the LPS of Escherichia coli O157 in patients with serum antibodies to E. coli O157 LPS

Henrik Chart, Neil T. Perry, Geraldine A. Willshaw and Thomas Cheasty

Laboratory of Enteric Pathogens, Division of Gastrointestinal Infections, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK

Correspondence Henrik Chart hchart{at}phls.org.uk

Received November 18, 2002
Accepted March 31, 2003

The salivary antibody response to the Escherichia coli O157 LPS antigen was assessed in 44 patients with serum antibodies binding to the LPS of E. coli O157. Saliva from 477 controls was also examined to assess the specificity of the immunoassay used. Twenty of the 44 patients had salivary antibodies to E. coli O157 LPS, giving the salivary antibody test a sensitivity of 0.45 and a predictive positive value for seropositivity of 1.00. The presence of these antibodies appeared not to relate to the time interval between serum sampling and saliva sampling. None of the 477 volunteers had salivary antibodies binding to the LPS of E. coli O157 alone; however, 15 had antibodies which bound non-specifically to both O157 LPS and BSA.


Abbreviations: HUS, haemolytic uraemic syndrome; VTEC, verocytotoxin-producing Escherichia coli.




This article has been cited by other articles:


Home page
J Med MicrobiolHome page
H. Chart and T. Cheasty
Human infections with verocytotoxin-producing Escherichia coli O157 - 10 years of E. coli O157 serodiagnosis
J. Med. Microbiol., November 1, 2008; 57(11): 1389 - 1393.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
A. M. Weisner, H. Chart, A. Bush, J. C. Davies, and T. L. Pitt
Detection of antibodies to Pseudomonas aeruginosa in serum and oral fluid from patients with cystic fibrosis
J. Med. Microbiol., May 1, 2007; 56(5): 670 - 674.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2003 Society for General Microbiology.